FAM72B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.603400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.954200E-01
Normal-vs-Stage2
7.532800E-01
Normal-vs-Stage3
5.186200E-01
Normal-vs-Stage4
8.342800E-01
Stage1-vs-Stage2
2.962800E-01
Stage1-vs-Stage3
5.324600E-01
Stage1-vs-Stage4
8.283600E-01
Stage2-vs-Stage3
1.809950E-01
Stage2-vs-Stage4
4.948800E-01
Stage3-vs-Stage4
4.554600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.641000E-01
Normal-vs-AfricanAmerican
9.371000E-01
Normal-vs-Asian
7.033800E-01
Caucasian-vs-AfricanAmerican
9.174800E-01
Caucasian-vs-Asian
7.665600E-01
AfricanAmerican-vs-Asian
7.049200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.034400E-01
Normal-vs-Female
8.173600E-01
Male-vs-Female
5.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.007200E-01
Normal-vs-Age(41-60Yrs)
7.877000E-01
Normal-vs-Age(61-80Yrs)
8.959000E-01
Normal-vs-Age(81-100Yrs)
7.481600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.372800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.834240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.256440E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.078600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.976000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.011800E-01
Normal-vs-Daily Drinker
9.969800E-01
Normal-vs-Weekly Drinker
6.119000E-01
Normal-vs-Occasional Drinker
8.794000E-01
Normal-vs-Social Drinker
8.521400E-01
Non Drinker-vs-Daily Drinker
5.449600E-01
Non Drinker-vs-Weekly Drinker
3.975600E-01
Non Drinker-vs-Occasional Drinker
8.063600E-01
Non Drinker-vs-Social Drinker
8.411200E-01
Daily Drinker-vs-Weekly Drinker
2.809200E-01
Daily Drinker-vs-Occasional Drinker
7.395800E-01
Daily Drinker-vs-Social Drinker
7.018200E-01
Weekly Drinker-vs-Occasional Drinker
3.873000E-01
Weekly Drinker-vs-Social Drinker
3.962000E-01
Occasional Drinker-vs-Social Drinker
9.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.969200E-01
Normal-vs-Grade 2
6.516800E-01
Normal-vs-Grade 3
6.746000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.015730E-02
Grade 1-vs-Grade 3
4.783400E-03
Grade 1-vs-Grade 4
5.969200E-01
Grade 2-vs-Grade 3
2.662600E-01
Grade 2-vs-Grade 4
6.516800E-01
Grade 3-vs-Grade 4
6.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.519800E-01
Normal-vs-NonDiabetic
7.720800E-01
Diabetic-vs-NonDiabetic
1.372780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.814800E-01
Normal-vs-NoPancreatitis
8.804400E-01
Pancreatitis-vs-NoPancreatitis
6.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.217200E-01
Normal-vs-N1
8.007000E-01
N0-vs-N1
4.402800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.177800E-01
Normal-vs-TP53-NonMutant
9.738000E-01
TP53-Mutant-vs-TP53-NonMutant
9.77559999948419E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
